Transce3nd’s Bruker BRKR Stock Holding History

Transce3nd’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4	Closed	-$235	–	1240
2024 Q4	$235	Buy	+4	New	+$236	﹤0.01%	1425

Other funds holding BRKR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Transce3nd's BRKR Position: Q1 2025 in Review

Transce3nd sold out of Bruker (BRKR) in Q1 2025, closing a stake of 4 shares — an estimated $235 sold.

Transce3nd first reported a position in BRKR in Q4 2024 and held it in 1 quarter. The position peaked at $235 in Q4 2024. 399 funds tracked by Wall St. Rank hold BRKR as of Q1 2025.

Transce3nd reported no remaining Bruker position as of Q1 2025 after selling out during the quarter.
Transce3nd sold 4 Bruker shares in Q1 2025, an estimated $235.
Transce3nd first reported a position in Bruker in Q4 2024 and held it in 1 quarter.
Transce3nd's Bruker position peaked at $235 in Q4 2024.
399 funds tracked by Wall St. Rank held Bruker as of Q1 2025.

Based on Transce3nd's 13F filing for Q1 2025, filed 5 May 2025.